Box Office Poison: Jim Carrey’s New Movie Went

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone PoemStone #31247
256
Box Office Poison: Jim Carrey’s New Movie Went Straight-to-Video

< >

Last year, Jim Carrey’s The Bad Batch, managed to gross just $181,000 in theaters — and that is the good news. Carrey’s latest movie, the $4.5 million thriller Dark Crimes, just went directly to home video.

Yep, for a measly $6.99, you can watch Jim Carrey’s latest in the comfort of your home; that is, if you really want to. Dark Crimes earned a bad-as-bad-can-be 0% at Rotten Tomatoes, so you might want to wait for Netflix, or skip it altogether.

What a fall.

What a collapse.

What a breathtaking implosion of the aging Carrey’s career, a juggernaut that began in 1994 with the come-from-nowhere blockbuster Ace Ventura: Pet Detective, and held on for another 14 years when Carrey’s name could still drive a forgettable piece junk like Yes Man to $97 million.

The last ten years have not been kind to the 56-year-old. I Love you, Phillip Morris was roundly ignored ($2 million). The high-concept (but lifeless) Mr. Popper’s Penguins probably failed to make its money back ($68 million). The Incredible Burt Wonderstone and Kick-Ass 2 were both stillborn ($22 million and $29 million). And while the labored and forgettable Dumb and Dumber To did okay ($86 million), all anyone remembers is how the magic disappeared.

On top of some awful professional choices, Carrey’s other mistake has been his determination to squander what once appeared to be an endless reservoir of goodwill with the public. America’s funnyman has become a sour, angry, hectoring scold; a bitter has been so out of touch with the common man, back in 2013, the Oscar-less Carrey thought it would be hilarious to mock Oscar-winner Charlton Heston in a Funny or Die music video — attack a man who had already been dead five years.

Carrey’s bad taste ended up backfiring in his face, specifically over these lyrics that falsely claimed Heston’s movies “are no longer in demand.”

Charlton Heston movies are no longer in demand
His immortal soul may lay forever in the sand
The angels wouldn’t take him up to heaven like he planned
‘Cause they couldn’t pry that gun from his cold dead hand

What was especially humiliating for Carrey is that later that same year, more people watched a 47-year-old rerun of a Charlton Heston movie on TV than saw Carrey’s newest movie.

Nevertheless, who would have ever guessed that Jim Carrey’s career could hit such a rock bottom, that a new Jim Carrey movie would be dumped into the direct-to-video bin, that the distributors would not even try to four-wall it somewhere to build buzz. But, you see, in order to do that, your star still has to be able to attract some kind of audience.

Sadly, those days are almost certainly over. On top of losing his edge and his audience, Carrey has devolved into a partisan and bitter scold, a mean-spirited jerk reduced to using what looks like crayons to scribble his daily dose of hate.

At age 76, Heston was still acting in movies directed by Oliver Stone, Tim Burton, Warren Beatty, and Michael Bay.

At age 56, Carrey is going straight-to-video and only able to garner attention using Twitter as the refrigerator upon which he scotch tapes his latest tantrum.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading